MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

ALIM

For the quarter ending 2024-06-30, ALIM made $27M in revenue. -$3.311M in net income. Net profit margin of -12.26%.

Overview

Revenue
$27M
Net Income
-$3.311M
Net Profit Margin
-12.26%
EPS
-$0.06
Unit: Million (M) dollars

Unit: Million (M) dollars (except for numbers of shares and EPS)
2024-06-30
Net revenue27
Us-gaap_costofgoodsandserviceexcludingdepreciationdepletionandamortization3.831
Us-gaap_grossprofit23.169
Sales and marketing expenses8.511
Research, development and medical affairs expenses4.263
General and administrative expenses7.379
Depreciation and amortization3.093
Us-gaap_operatingexpenses23.246
Us-gaap_operatingincomeloss-0.077
Us-gaap_interestexpense3.153
Unrealized foreign currency loss, net-0.125
Change in fair value of warrant asset0.001
Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest-3.354
Us-gaap_incometaxexpensebenefit-0.043
Net loss-3.311
Us-gaap_netincomelossavailabletocommonstockholdersbasic-3.311
Basic eps-0.06
Basic average shares54,383,604
Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Us-gaap_netincomelossavailabletocommonstockholdersbasic-$3.311M Net loss-$3.311M Us-gaap_incometaxexpensebenefit-$0.043M Us-gaap_incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest-$3.354M Change in fair value ofwarrant asset$0.001M Net revenue$27M Unrealized foreigncurrency loss, net-$0.125M Us-gaap_interestexpense$3.153M Us-gaap_operatingincomeloss-$0.077M Us-gaap_grossprofit$23.169M Us-gaap_costofgoodsandserviceexcludingdepreciationdepletionandamortization$3.831M Us-gaap_operatingexpenses$23.246M Depreciation andamortization$3.093M General andadministrative expenses$7.379M Research, development andmedical affairs...$4.263M Sales and marketingexpenses$8.511M